Results 1 to 10 of about 1,559,633 (249)
Solid pseudopapillary neoplasm of the pancreas
World Journal of Hepatology, 2021 Solid pseudopapillary neoplasms are rare. This article reviews the clinical and pathologic features of solid pseudopapillary neoplasm of the pancreas, including the epidemiology, cytology, molecular pathology, differential diagnosis, treatment, and ...
A. Omiyale
semanticscholar +1 more source
Pancreatic Solid Pseudopapillary Neoplasm: Key Pathologic and Genetic Features.
Archives of Pathology & Laboratory Medicine, 2020 CONTEXT.— Solid pseudopapillary neoplasm of the pancreas is a low-grade malignant tumor generally associated with a good prognosis. Solid pseudopapillary neoplasms show peculiar morphologic features, but sometimes the differential diagnosis with other ...
S. Rosa, M. Bongiovanni
semanticscholar +1 more source
Neuroendocrine neoplasm update: toward universal nomenclature.
Endocrine-Related Cancer, 2020 Neuroendocrine neoplasia is described in almost every tissue, either in the pure endocrine organs, the nerve structures or in the so-called diffuse neuroendocrine system. The current nomenclature contains time-honored widely accepted definitions; however,
G. Rindi, F. Inzani
semanticscholar +1 more source
Sex differences in solid pseudopapillary neoplasm of the pancreas: A population‐based study
Cancer Medicine, 2020 Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare tumor. This study aims to examine the clinicopathological features and surgical treatments of SPN and compare the clinical behavior and prognosis between men and women with SPN.
Jiali Wu +6 more
semanticscholar +1 more source
Tagraxofusp in Blastic Plasmacytoid Dendritic‐Cell Neoplasm
New England Journal of Medicine, 2019 Background Blastic plasmacytoid dendritic‐cell neoplasm (BPDCN) is an aggressive hematologic cancer that is caused by transformed plasmacytoid dendritic cells that overexpress interleukin‐3 receptor subunit alpha (IL3RA or CD123). Tagraxofusp (SL‐401) is
N. Pemmaraju +17 more
semanticscholar +1 more source
Neoplasm Risk Among Individuals With a Pathogenic Germline Variant in DICER1.
Journal of Clinical Oncology, 2019 PURPOSE DICER1 syndrome is an autosomal-dominant, pleiotropic tumor-predisposition disorder caused by pathogenic germline variants in DICER1. We sought to quantify risk, hazard rates, and the probability of neoplasm incidence accounting for competing ...
D. Stewart +11 more
semanticscholar +1 more source
BMC Cancer, 2018 Pancreatic cancer is associated with an extremely poor prognosis, so new biomarkers that can detect the initial stages are urgently needed. The significance of serum microRNA (miR) levels in pancreatic neoplasm such as pancreatic cancer and intraductal ...
T. Goto +18 more
semanticscholar +1 more source
JAMA Surgery, 2019 Importance The step after conservative treatment of periappendicular abscess arouses controversy, ranging from recommendations to abandon interval appendectomy based on low recurrence rates of the precipitating diagnosis to performing routine interval ...
Jari Mällinen +8 more
semanticscholar +1 more source
Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects
Cancers, 2019 Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which usually affects elderly males and presents in the skin with frequent involvement of the bone-marrow, peripheral blood and lymph nodes. It has a dismal prognosis, with
M. Sapienza +9 more
semanticscholar +1 more source
Blastic plasmacytoid dendritic cell neoplasm
Clinical Case Reports, 2018 Blastic plasmacytoid dendritic cell neoplasm is an aggressive neoplasm with a median survival of only a few months despite treatment. An exhaustive immunohistochemical workup is required to differentiate it from myeloid sarcoma and extranodal NK/T cell ...
M. Rai +4 more
semanticscholar +1 more source